​

Funding Round

Series A - SonoThera

Series A - SonoThera

Investment Firm

Overview

SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound.

Announced Date

Dec 05, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

ARCH Venture Partners

ARCH Venture Partners

ARCH Venture Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

7

Investor Name
Participant InvestorAlexandria Venture Investments
Participant InvestorEli Lilly & Company Foundation
Participant InvestorIllumina Ventures
Participant InvestorARCH Venture Partners
Participant InvestorWilson Sonsini Goodrich & Rosati

Round Details and Background

SonoThera raised $60750000 on 2022-12-05 in Series A

SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 05, 2022
Series A - SonoThera
11-60.8M

Recent Activity

There is no recent news or activity for this profile.